ASPREE-NEURO study protocol: A randomized controlled trial to determine the effect of low-dose aspirin on cerebral microbleeds, white matter hyperintensities, cognition, and stroke in the healthy elderly
Stephanie A Ward, Parnesh Raniga, Nicholas J Ferris, Robyn L Woods, Elsdon Storey, Michael J Bailey, Amy Brodtmann, Paul A Yates, Geoffrey A Donnan, Ruth E Trevaks, Rory Wolfe, Gary F Egan, John J McNeil
International Journal of Stroke | SAGE PUBLICATIONS LTD | Published : 2017
Awarded by National Institute on Aging
Awarded by Australian National Health and Medical Research Council (NHMRC)
Awarded by NHMRC
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The ASPREE study has been funded principally by the National Institute on Aging (grant number 1RO1AG029824-01A2), the Australian National Health and Medical Research Council (NHMRC) (grant number 334047), Monash University and the Victorian Cancer Agency. ASPREE-NEURO has funding from the NHMRC (grant number 1086188), and support from Monash Biomedical Imaging.